0

542248

DECCAN

img img img img
No Data Available

Deccan Health Care Limited Share Price Update

As of the latest trading session, Deccan Health Care Limited share price is currently at ₹10.86, which is down by ₹-0.19 from its previous closing. Today, the stock has fluctuated between ₹10.78 and ₹11.26. Over the past year, Deccan Health Care Limited has achieved a return of -33.62%. In the last month alone, the return has been -13.03%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Deccan Health Care Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    29.60

  • P/E Ratio (TTM)

    13.57

  • Beta

    0.25

  • Book Value / share

    44.02

  • Return on equity

    1.18%

  • EPS (TTM)

    0.89

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.95

info icon alternate text

Deccan Health Care Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 23.03
Operating Expense 21.74
Net Profit 0.95
Net Profit Margin (%) 4.12
Earnings Per Share (EPS) 0.38
EBITDA 1.68
Effective Tax Rate (%) 26.35
Particulars SEP 2025 (Values in Cr)
Revenue 24.40
Operating Expense 23.18
Net Profit 0.90
Net Profit Margin (%) 3.68
Earnings Per Share (EPS) 0.36
EBITDA 1.71
Effective Tax Rate (%) 26.22
Particulars JUN 2025 (Values in Cr)
Revenue 21.47
Operating Expense 21.18
Net Profit 0.21
Net Profit Margin (%) 0.97
Earnings Per Share (EPS) 0.09
EBITDA 0.73
Effective Tax Rate (%) 30.00
Particulars MAR 2025 (Values in Cr)
Revenue 20.82
Operating Expense 20.58
Net Profit 0.14
Net Profit Margin (%) 0.67
Earnings Per Share (EPS) 0.06
EBITDA 0.63
Effective Tax Rate (%) 44.00
Particulars DEC 2024 (Values in Cr)
Revenue 20.43
Operating Expense 20.22
Net Profit 0.16
Net Profit Margin (%) 0.78
Earnings Per Share (EPS) 0.07
EBITDA 0.60
Effective Tax Rate (%) 28.57
Particulars MAR 2025 (Values in Cr)
Revenue 75.13
Operating Expense 73.46
Net Profit 1.20
Net Profit Margin (%) 1.59
Earnings Per Share (EPS) 0.56
EBITDA 3.19
Effective Tax Rate (%) 28.14
Particulars MAR 2024 (Values in Cr)
Revenue 59.73
Operating Expense 57.50
Net Profit 1.52
Net Profit Margin (%) 2.54
Earnings Per Share (EPS) 0.82
EBITDA 3.77
Effective Tax Rate (%) 32.14
Particulars MAR 2023 (Values in Cr)
Revenue 45.02
Operating Expense 44.50
Net Profit 0.40
Net Profit Margin (%) 0.88
Earnings Per Share (EPS) 0.24
EBITDA 2.07
Effective Tax Rate (%) 24.52
Particulars MAR 2022 (Values in Cr)
Revenue 33.17
Operating Expense 29.45
Net Profit 0.32
Net Profit Margin (%) 0.96
Earnings Per Share (EPS) 0.21
EBITDA 2.16
Effective Tax Rate (%) 40.74
Particulars MAR 2021 (Values in Cr)
Revenue 33.78
Operating Expense 33.31
Net Profit 0.39
Net Profit Margin (%) 1.15
Earnings Per Share (EPS) 0.25
EBITDA 2.10
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 44.94
ROE % 1.14
ROCE % 1.64
Total Debt to Total Equity 0.01
EBITDA Margin 4.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.90
ROE % 1.67
ROCE % 2.52
Total Debt to Total Equity 0.02
EBITDA Margin 6.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.86
ROE % 0.39
ROCE % 0.68
Total Debt to Total Equity 0.02
EBITDA Margin 4.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.97
ROE % 3.00
ROCE % 5.60
Total Debt to Total Equity 0.01
EBITDA Margin 17.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.76
ROE % 0.51
ROCE % 0.81
Total Debt to Total Equity 0.01
EBITDA Margin 6.22
Particulars MAR 2025 (Values in Cr)
Book Value / Share 45.01
ROE % 1.18
ROCE % 1.69
Total Debt to Total Equity 0.01
EBITDA Margin 4.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.96
ROE % 1.70
ROCE % 2.53
Total Debt to Total Equity 0.02
EBITDA Margin 6.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.91
ROE % 0.50
ROCE % 0.79
Total Debt to Total Equity 0.02
EBITDA Margin 4.60
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.97
ROE % 3.00
ROCE % 5.60
Total Debt to Total Equity 0.01
EBITDA Margin 17.64
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.76
ROE % 0.51
ROCE % 0.81
Total Debt to Total Equity 0.02
EBITDA Margin 6.22
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.55
Total Assets 124.92
Total Liabilities 124.92
Total Equity 106.39
Share Outstanding 2
Price to Book Ratio 0.38
Return on Assets (%) 0.92
Return on Capital (%) 1.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.60
Total Assets 108.04
Total Liabilities 108.04
Total Equity 96.91
Share Outstanding 2
Price to Book Ratio 0.59
Return on Assets (%) 1.38
Return on Capital (%) 1.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.41
Total Assets 96.78
Total Liabilities 96.78
Total Equity 81.56
Share Outstanding 1
Price to Book Ratio 0.57
Return on Assets (%) 0.31
Return on Capital (%) 0.37
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 90.62
Total Liabilities 90.62
Total Equity 76.94
Share Outstanding 1
Price to Book Ratio 0.73
Return on Assets (%) 0.35
Return on Capital (%) 0.41
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 92.26
Total Liabilities 92.26
Total Equity 76.62
Share Outstanding 1
Price to Book Ratio 0.60
Return on Assets (%) 0.42
Return on Capital (%) 0.5
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.48
Total Assets 123.93
Total Liabilities 123.93
Total Equity 106.55
Share Outstanding 2
Price to Book Ratio 0.38
Return on Assets (%) 0.96
Return on Capital (%) 1.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.22
Total Assets 107.32
Total Liabilities 107.32
Total Equity 97.03
Share Outstanding 2
Price to Book Ratio 0.59
Return on Assets (%) 1.41
Return on Capital (%) 1.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.36
Total Assets 96.47
Total Liabilities 96.47
Total Equity 81.65
Share Outstanding 1
Price to Book Ratio 0.57
Return on Assets (%) 0.41
Return on Capital (%) 0.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 90.62
Total Liabilities 90.62
Total Equity 76.94
Share Outstanding 1
Price to Book Ratio 0.73
Return on Assets (%) 0.35
Return on Capital (%) 0.42
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.21
Total Assets 92.26
Total Liabilities 92.26
Total Equity 76.62
Share Outstanding 1
Price to Book Ratio 0.60
Return on Assets (%) 0.42
Return on Capital (%) 0.5
Particulars MAR 2025 (Values in Cr)
Net Income 1.63
Cash from Operations -6.41
Cash from Investing -0.13
Cash from Financing 7.51
Net change in Cash 0.95
Free Cash Flow -6.27
Particulars MAR 2024 (Values in Cr)
Net Income 2.21
Cash from Operations -12.54
Cash from Investing -0.29
Cash from Financing 14.04
Net change in Cash 1.19
Free Cash Flow -12.23
Particulars MAR 2023 (Values in Cr)
Net Income 0.43
Cash from Operations -6.54
Cash from Investing 0.27
Cash from Financing 5.26
Net change in Cash -1.23
Free Cash Flow -6.54
Particulars MAR 2022 (Values in Cr)
Net Income 3.94
Cash from Operations -0.32
Cash from Investing -0.04
Cash from Financing 0.06
Net change in Cash -0.55
Free Cash Flow -0.20
Particulars MAR 2021 (Values in Cr)
Net Income 0.51
Cash from Operations 0.35
Cash from Investing -0.07
Cash from Financing -0.37
Net change in Cash -0.22
Free Cash Flow 0.45
Particulars MAR 2025 (Values in Cr)
Net Income 1.66
Cash from Operations -6.59
Cash from Investing -0.13
Cash from Financing 8.00
Net change in Cash 1.26
Free Cash Flow -6.45
Particulars MAR 2024 (Values in Cr)
Net Income 2.24
Cash from Operations -12.47
Cash from Investing -0.29
Cash from Financing 13.64
Net change in Cash 0.86
Free Cash Flow -12.16
Particulars MAR 2023 (Values in Cr)
Net Income 0.53
Cash from Operations -6.37
Cash from Investing 0.26
Cash from Financing 5.05
Net change in Cash -1.27
Free Cash Flow -6.37
Particulars MAR 2022 (Values in Cr)
Net Income 3.94
Cash from Operations -0.32
Cash from Investing -0.04
Cash from Financing 0.06
Net change in Cash -0.55
Free Cash Flow -0.20
Particulars MAR 2021 (Values in Cr)
Net Income 0.51
Cash from Operations 0.35
Cash from Investing -0.08
Cash from Financing -0.37
Net change in Cash -0.23
Free Cash Flow 0.44
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7492.85 59.31 11.85 107735.69 6017.95 8099.00
FORTIS MALAR HOSPITALS LIMITED 50.59 20.90 2.75 94.81 46.65 98.70
SHREE PACETRONIX LTD. 107.85 15.93 2.42 39.63 61.11 283.15
TRANSGENE BIOTEK LTD. 2.43 0.00 1.99 18.41 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7492.85 74.18 11.56 107735.69 6017.95 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.06 0.00 -10.76 27.68 28.34 57.48
KOVAI MEDICAL CENTER & HOSPITA 5106.00 23.69 4.69 5585.96 5049.80 6725.00

Deccan Health Care Limited shareholding pattern

Holding

76.2%
18.41%
5.37%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Deccan Health Care Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
11.95 -1.07 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 12.60
  • 26 Days 13.30
  • 10 Days 12.80
  • 50 Days 13.80
  • 12 Days 12.90
  • 100 Days 14.90
  • 20 Days 13.10
  • 200 Days 17.00
12.41 PIVOT

First Support

11.32

First Resistance

13.17

Second Support

10.56

Second Resistance

14.26

Third Support

9.47

Third Resistance

15.02

RSI

34.66

ADX

20.48

MACD

-0.39

Williams % R

-83.46

Commodity Channel Index (CCI)

-143.38

Date

2026-03-16

Week

62695.00

Same Day

139095.00

Month

28404.00

1 Year

0.25

3 Year

0.71

Over 1 Month

-13.03%

down

Over 1 Year

-33.62%

down

Over 3 Months

-24.26%

down

Over 3 Years

-25.55%

down

Over 6 Months

-39.53%

down

Over 5 Years

-16.55%

down

Deccan Health Care Limited Corporate Actions

Top Gainers

Deccan Health Care Limited Share Price

Incorporated on August 31, 2017, Deccan Health Care Limited is developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. With an operating history of more than two decades, the company is primarily known for premium range of nutraceutical, ayurveda and cosmeceutical products. The Company has identified over 80 consumer wellness goals and over 250 diseases, disorders, disabilities which can be prevented by meeting RDA of micronutrients and it has innovated and developed cost effective products that are unique and differentiated to combat such diseases.

The Company was initially engaged in trading of Pharmaceuticals till 2005. From 2005 till 2010 the company was engaged in third party manufacturing. From 2010 onwards, the Company set up its own Manufacturing Facility at Rudrapur, Uttarakhand. The quality of its products is evidenced by the number of quality certifications that the Company has obtained from various local and international accredition agencies. This facility complies with GMP and WHO GMP for its health / diet supplements and ayurvedic products. The Company has also obtained FSSAI license for its products. The Company is also an ISO 9001:2008 certified for Quality management System for manufacturing and supply of Nutraceutical & Pharmaceutical Products. The R&D capabilities enabled the Company to support growth strategy by developing new products and process which enhance its range of products and services.

Apart from this, the Company mainly develop and market differentiated healthcare products specializing in nutraceutical and
cosmeceutical products, which it commercialize through different revenue channels that takes the products solutions to consumers which includes network of distributors, influencers, direct to consumers and e-commerce channel for our domestic sales.

In November 2018, the Company came with an IPO of 42,12,000 Equity Shares comprising of a Fresh Issue of 20,12,000 Equity Shares and an Offer for Sale of 20,00,000 Equity Shares.

In 2019, the Company launched ZnC, an advanced immunity booster, Super Orange chewable delivers a citrus-y-burst of essential nutrients including Zinc and Vitamin C. It also launched Protein +Delicious Protein with Natural Coffee, a unique blend formulated from the union of Protein, Coffee and 75 Micronutrients selected directly from the best harvests.

The Company launched Royal Tea Tree Body Wash; omega 3 hair oil Sachets, Ubtan Body wash, Nurovit MC Total, Sonehaldi and Orthomega during the FY 2021-22. It focused on nutrition-led health solutions by accelerating the fight against iron deficiency with an innovative, food based strategy in 2023-24.

Parent organization Indian Private
NSE symbol [-]
Founded 1996
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Deccan Health Care Ltd?

Answer Field

Deccan Health Care Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.00 as on Mar 20 2026 03:27 PM.

What is the Market Cap of Deccan Health Care Ltd Share?

Answer Field

The market cap of Deccan Health Care Ltd for NSE ₹ 0.00 & for BSE ₹ 29.70 as on Mar 20 2026 03:27 PM.

What is the 52 Week High and Low of Deccan Health Care Ltd?

Answer Field

The 52 Week High and Low of Deccan Health Care Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 24.40 and ₹ 11.65.

What is 1 year return for Deccan Health Care Ltd?

Answer Field

The 1 year returns on the stock has been -33.62%.

What is the P/E Ratio of Deccan Health Care Ltd Share?

Answer Field

As on Mar 20 2026 03:27 PM the price-to-earnings (PE) ratio for Deccan Health Care Ltd share is 13.57.

What is the PB ratio of Deccan Health Care Ltd Share?

Answer Field

As on Mar 20 2026 03:27 PM, the price-to-book (PB) ratio for Deccan Health Care Ltd share is 44.02.

How to Buy Deccan Health Care Ltd Share?

Answer Field

You can trade in Deccan Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Deccan Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Deccan Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Deccan Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59